Abbott Laboratories Stock price

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
113.7 USD +0.16% Intraday chart for Abbott Laboratories +1.93% +3.26%
Sales 2024 * 41.98B Sales 2025 * 44.97B Capitalization 197B
Net income 2024 * 6B Net income 2025 * 6.94B EV / Sales 2024 * 4.77 x
Net Debt 2024 * 3.14B Net cash position 2025 * 1.23B EV / Sales 2025 * 4.36 x
P/E ratio 2024 *
32.9 x
P/E ratio 2025 *
28.5 x
Employees 114,000
Yield 2024 *
1.9%
Yield 2025 *
2.04%
Free-Float 86.76%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.16%
1 week+1.93%
Current month-4.20%
1 month-5.32%
3 months+2.95%
6 months+15.84%
Current year+3.26%
More quotes
1 week
109.11
Extreme 109.11
114.02
1 month
109.11
Extreme 109.11
121.64
Current year
109.11
Extreme 109.11
121.64
1 year
89.67
Extreme 89.674
121.64
3 years
89.67
Extreme 89.674
142.60
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 14-12-31
Director of Finance/CFO 51 96-12-31
Chief Tech/Sci/R&D Officer - 89-12-31
Members of the board TitleAgeSince
Director/Board Member 69 17-02-15
Director/Board Member 63 17-06-28
Director/Board Member 65 11-12-08
More insiders
Date Price Change Volume
24-03-28 113.7 +0.16% 5,278,215
24-03-27 113.5 +1.78% 7,533,356
24-03-26 111.5 +1.35% 7,770,829
24-03-25 110 -0.51% 6,622,414
24-03-22 110.6 -0.84% 5,387,719

Delayed Quote Nyse, March 28, 2024 at 04:00 pm EDT

More quotes
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
113.7 USD
Average target price
125.5 USD
Spread / Average Target
+10.39%
Consensus
  1. Stock
  2. Equities
  3. Stock Abbott Laboratories - Nyse